Pfizer Licensing, Development & Alliances
The Process
Partnering and collaboration is important to Pfizer.
We have implemented an infrastructure and process to allow careful and considerate review of every opportunity we receive by a team of scientific and business experts.
All therapeutic, technology and business areas have dedicated teams to manage the entire evaluation and collaboration process.
Key Stages of the Process
Our aim is to conduct timely and efficient, but thorough evaluation of every potential opportunity.
First, we evaluate non-confidential information and data.
If appropriate, a confidentiality agreement is signed, confidential data is reviewed, and scientific, legal and financial due diligence is conducted.
Subject to internal approval, we will then proceed to negotiation and execution of a contract.
After contract signing, we remain actively involved with the opportunity to ensure its mutual success.

